Abstract
Background
High pulsatile pressure and flow in the arteries causes microvascular damage, and hence increased cardio-, and cerebrovascular complications. With advanced stages of hypertensive disease, an exaggerated pulsatile retinal capillary flow (RCF) has been shown, but data about interventional effect are missing.
Methods
Fifty-one patients with true treatment-resistant hypertension (TRH) underwent renal denervation (RDN) using the Symplicity Flex™ catheter and were followed for 12 months. RCF was assessed non-invasively using Scanning laser Doppler flowmetry (SLDF) before, 6 (6 M), and 12 (12 M) months after RDN. RCF was measured in systole and diastole and pulsed RCF (difference of RCF in systole minus diastole) was calculated. In addition, flicker light-induced vasodilation (representing vasodilatory capacity) was assessed.
Results
Systolic and diastolic office blood pressure (BP) as well as 24-h ABPM decreased significantly 6 M and 12 M after RDN, compared to baseline values (all p < 0.001). There was a significant reduction of pulsed RCF 6 M (231 ± 81 versus 208 ± 68 AU, p = 0.046) and 12 M (194 ± 72 AU, p = 0.001) after RDN, whereas the mean RCF was unchanged. Moreover, there was a significant increase of flicker light-induced vasodilation after RDN (p = 0.043).
Conclusion
In hypertensive patients with TRH, we observed a decrease of pulsed RCF 6 M and 12 M after RDN and an increase of vasodilatory capacity, in parallel to decreases in BP and heart rate. The reduction of pulsed RCF after RDN implies a decrease of shear stress on the vascular wall by the pulsed blood flow. This and the increment of vasodilatory capacity suggest an improvement of retinal (and potentially cerebral) microcirculation.
Similar content being viewed by others
References
O’Rourke MF, Safar ME (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46:200–204
Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, Lodder J, de Leeuw PW (2008) Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 52:1120–1126
Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A (2007) Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens 25:1915–1920
Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE (2004) Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke J Cerebral Circ 35:1289–1293
Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJ (1996) Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma 5:99–105
Michelson G, Welzenbach J, Pal I, Harazny J (1998) Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol 82:1294–1300
Kreis AJ, Nguyen T, Rogers S, Wang JJ, Harazny J, Michelson G, Farouque HM, Wong TY (2008) Reliability of different image analysis methods for scanning laser Doppler flowmetry. Curr Eye Res 33:493–499
Harazny JM, Ott C, Raff U, Welzenbach J, Kwella N, Michelson G, Schmieder RE (2014) First experience in analysing pulsatile retinal capillary flow and arteriolar structural parameters measured noninvasively in hypertensive patients. J Hypertens 32:2246–2252
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–1281
Symplicity HTNI, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909
Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Bohm M, Schmieder RE (2013) Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol 62:1880–1886
Poss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D, Cremers B, Laufs U, Bohm M (2014) Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol Off J Ger Cardiac Soc 103:41–47
Vogel B, Kirchberger M, Zeier M, Stoll F, Meder B, Saure D, Andrassy M, Mueller OJ, Hardt S, Schwenger V, Strothmeyer A, Katus HA, Blessing E (2014) Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol Off J Ger Cardiac Soc 103:117–124
Patel HC, Dhillon PS, Mahfoud F, Lindsay AC, Hayward C, Ernst S, Lyon AR, Rosen SD, di Mario C (2014) The biophysics of renal sympathetic denervation using radiofrequency energy. Clin Res Cardiol Off J Ger Cardiac Soc 103:337–344
Linz D, Bohm M (2015) Renal denervation for treatment of hypertension and beyond. Clin Res Cardiol Off J Ger Cardiac Soc 104:87–88
Hilbert S, Rogge C, Papageorgiou P, Hindricks G, Bollmann A (2014) Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia, Clin Res Cardiol Off J Ger Cardiac Soc 104:279–281
Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Bohm M, Schmieder RE (2014) Improvement of albuminuria after renal denervation. Int J Cardiol 173:311–315
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, L. National Heart, D.E. Blood Institute Joint National Committee on Prevention, P. Treatment of High Blood, C. National High Blood Pressure Education Program Coordinating (2003) The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA J Am Med Assoc 289:2560–2572
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force M (2013) ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(2013):1281–1357
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C (2012) ESH position paper: renal denervation—an interventional therapy of resistant hypertension. J Hypertens 30:837–841
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C, European Society of hypertension (2013) Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention 9(Suppl R):R58–R66
Mahfoud F, Luscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefevre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Bohm M, European Society of Cardiology (2013) Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 34:2149–2157
Harazny JM, Schmieder RE, Welzenbach J, Michelson G (2013) Local application of tropicamide 0.5 % reduces retinal capillary blood flow. Blood Press 22:371–376
Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G, Schmieder RE (2011) New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens 29:777–782
Ott C, Schlaich MP, Harazny J, Schmidt BM, Michelson G, Schmieder RE (2008) Effects of angiotensin II type 1-receptor blockade on retinal endothelial function. J Hypertens 26:516–522
Rizzoni D, Porteri E, Duse S, De Ciuceis C, Rosei CA, La Boria E, Semeraro F, Costagliola C, Sebastiani A, Danzi P, Tiberio GA, Giulini SM, Docchio F, Sansoni G, Sarkar A, Rosei EA (2012) Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens 30:1169–1175
Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L (2003) Nitric oxide regulates retinal vascular tone in humans, American journal of physiology. Heart Circ Physiol 285:H631–H636
Nagel E, Vilser W, Lanzl I (2004) Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci 45:1486–1492
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ (2011) Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik study. Brain J Neurol 134:3398–3407
Wohlfahrt P, Krajcoviechova A, Jozifova M, Mayer O, Vanek J, Filipovsky J, Laurent S, Cifkova R (2014) Large artery stiffness and carotid flow pulsatility in stroke survivors. J Hypertens 32:1097–1103 discussion 1103
Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME (2000) Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 160:1085–1089
Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M, Ducimetiere P, Guize L (2000) A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 35:673–680
Alderman MH, Cohen H, Madhavan S (1998) Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 16:761–769
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL, Investigators RR (2013) Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J 34:1204–1214
Acknowledgments
The authors thank the study nurses (CRC), as well as the assistant personal of the angiography lab for invaluable support with patient management.
Conflict of interest
AS has received speaker fees from Medtronic. RES has received travel support, speaker and consultancy fees and institutional grants from Medtronic.
Author information
Authors and Affiliations
Corresponding author
Additional information
C. Ott and J. M. Harazny contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Ott, C., Harazny, J.M., Schmid, A. et al. Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients. Clin Res Cardiol 104, 782–789 (2015). https://doi.org/10.1007/s00392-015-0845-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0845-0